Does CETUXIMAB Cause Neoplasm progression? 118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Neoplasm progression have been filed in association with CETUXIMAB (ERBITUX). This represents 0.8% of all adverse event reports for CETUXIMAB.
118
Reports of Neoplasm progression with CETUXIMAB
0.8%
of all CETUXIMAB reports
48
Deaths
30
Hospitalizations
How Dangerous Is Neoplasm progression From CETUXIMAB?
Of the 118 reports, 48 (40.7%) resulted in death, 30 (25.4%) required hospitalization, and 2 (1.7%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which CETUXIMAB Alternatives Have Lower Neoplasm progression Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL